In Vivo Selection for Human and Murine Hematopoietic Cells Transduced with a Therapeutic MGMT Lentiviral Vector that Inhibits HIV Replication
Open Access
- 1 February 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (2), 160-172
- https://doi.org/10.1016/j.ymthe.2003.11.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trialBlood, 2002
- Antiretroviral-Drug Resistance among Patients Recently Infected with HIVNew England Journal of Medicine, 2002
- Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacementNature Medicine, 2002
- Long-term Exposure to Lifelong TherapiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infectionNature Medicine, 2002
- Lipodystrophy Syndrome in HIV InfectionDrug Safety, 2000
- A Clinical Trial of Retroviral-Mediated Transfer of arev-Responsive Element Decoy Gene Into CD34+Cells From the Bone Marrow of Human Immunodeficiency Virus-1–Infected ChildrenBlood, 1999
- Retroviral Transfer of the Glucocerebrosidase Gene into CD34+Cells from Patients with Gaucher Disease:In VivoDetection of Transduced Cells without MyeloablationHuman Gene Therapy, 1998
- Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous diseaseProceedings of the National Academy of Sciences, 1997
- A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.Proceedings of the National Academy of Sciences, 1996